Herein, we demonstrate a protective role of NO2-OA in an ALS model due to its ability to cross the BBB and (a) down-modulate PGHS- and LOX-derived inflammatory products and (b) induce HO-1 expression in reactive glia from spinal cord associated to improvement of motor performance. Here, LOX is linked to amyotrophic lateral sclerosis.